Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 721, Issue 1-3, 2013, Pages 355-364

  Liu, Yao Wu ^a   Zhu, Xia ^a   Zhang, Liang ^a   Lu, Qian ^a   Wang, Jian Yun ^a   Zhang, Fan ^a   Guo, Hao ^a   Yin, Jia Le ^a   Yin, Xiao Xing ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AGEs RAGE; Diabetes nephropathy; Glyoxalase 1; Mangiferin; Oxidative stress

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; GLUCOSE; GLUTATHIONE; LACTOYLGLUTATHIONE LYASE; MALONALDEHYDE; MANGIFERIN; MESSENGER RNA;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULAR EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY DYSFUNCTION; KIDNEY MASS; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

AGES/RAGE; DIABETES NEPHROPATHY; GLYOXALASE 1; MANGIFERIN; OXIDATIVE STRESS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FASTING; GLYCOSYLATION END PRODUCTS, ADVANCED; LACTOYLGLUTATHIONE LYASE; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; UP-REGULATION; XANTHONES;

EID: 84890120886     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.08.029     Document Type: Article

References (49)

1. P. Beisswenger, S. Jean, T. Brinck-Johnsen, A. Siegel, and J. Cavender Acetol production is increased in early diabetic nephropathy [Abstract] Diabetes 44 1995 23A
2. P. Beisswenger, A. Touchette, and S. Howell The effect of hyperglycaemia and diabetes on methylglyoxal and its detoxification pathways (Abstract) Diabetologia 40 suppl. 1 1997 588 (I-V)
3. P.J. Boor, M.B. Trent, G.A. Lyles, M. Tao, and G.A.S. Ansari Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase Toxicology 73 1992 251 258
4. D. Edelstein, and M. Brownlee Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine Diabetes 41 1992 26 29
5. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820 (Pubitemid 34000785)
6. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625 (Pubitemid 40770750)
7. M. Brownlee, A. Cerami, and H. Vlassara Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications New England Journal of Medicine 318 1988 1315 1321
8. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking Science 232 1986 1629 1632 (Pubitemid 16095602)
9. O. Brouwers, P.M. Niessen, I. Ferreira, T. Miyata, P.G. Scheffer, T. Teerlink, P. Schrauwen, M. Brownlee, C.D. Stehouwer, and C.G. Schalkwijk Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats Journal of Biological Chemistry 286 2011 1374 1380
10. S. Di Loreto, V. Zimmitti, P. Sebastiani, C. Cervelli, S. Falone, and F. Amicarelli Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons International Journal of Biochemistry and Cell Biology 40 2008 245 257 (Pubitemid 350137877)
11. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
12. Z.H. Guo, R.G. Xi, X.B. Wang, L.J. Wu, and H.Y. Gao A new trincallane derivative from Salacia hainanensis Chun et How Yao Xue Xue Bao 44 2009 1123 1126 (in Chinese)
13. N. Kashihara1, Y. Haruna1, V.K. Kondeti, and Y.S. Kanwar Oxidative stress in diabetic nephropathy Current Medicinal Chemistry 17 2010 4256 4269
14. M. Kalousova, t. Zima, V. Tesar, S. Dusilova-Sulkova, and J. Skrha Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background Mutation Research 579 2005 37 46 (Pubitemid 41540131)
15. X. Li, X.B. Cui, X.Y. Sun, X.D. Li, Q. Zhu, and W. Li Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats Phytotherapy Research 24 2010 893 899
16. J. Lu, E. Randell, Y. Han, K. Adeli, J. Krahn, and Q.H. Meng Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy Clinical Biochemistry 44 2011 307 311
17. Y.W. Liu, X. Zhu, W. Li, Q. Lu, J.Y. Wang, Y.Q. Wei, and X.X. Yin Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats Pharmacology, Biochemistry and Behavior 101 2012 93 98
18. P. Maher, R. Dargusch, J.L. Ehren, S. Okada, K. Sharma, and D. David Schubert Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes PLoS One 6 2011 e21226
19. S. Muruganandan, S. Gupta, M. Kataria, J. Lal, and P.K. Gupta Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats Toxicology 176 2002 165 173 (Pubitemid 34692590)
20. L. Marquez, B. Garcia-Bueno, J.L. Madrigal, and J.C. Leza Mangiferin decreases inflammation and oxidative damage in rat brain after stress European Journal of Nutrition 51 2012 729 739
21. T. Miyata, O. Hori, J.H. Zhang, S.D. Yan, L. Ferran, Y. Iida, and A.M. Schmidt The receptor for advanced glycation endproducts mediates the interaction of AGE-β2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implication for the pathogenesis of dialysis-related amyloidosis Journal of Clinical Investigation 98 1996 1088 1094 (Pubitemid 26299919)
22. T. Miura, H. Ichiki, N. Iwamoto, M. Kato, M. Kubo, H. Sasak, M. Okada, T. Ishida, Y. Seino, and K. Tanigawa Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside Biological and Pharmaceutical Bulletin 24 2001 1009 1011 (Pubitemid 32894119)
23. S. Muruganandan, K. Srinivasan, S. Gupta, P.K. Gupta, and J. Lal Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats Journal of Ethnopharmacology 97 2005 497 501 (Pubitemid 40312325)
24. T. Miyata, , T. Imasawa, A. Yoshino, Y. Ueda, H. Ogura, K. Kominami, H. Onogi, R. Inagi, M. Nangaku, and K. Kurokawa Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient Kidney International 60 2001 2351 2359 (Pubitemid 33070479)
25. K.M. Myint, Y. Yamamoto, T. Doi, I. Kato, A. Harashima, H. Yonekura, T. Watanabe, H. Shinohara, M. Takeuchi, K. Tsuneyama, N. Hashimoto, M. Asano, S. Takasawa, H. Okamoto, and H. Yamamoto RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low molecular weight heparin Diabetes 55 2006 2510 2522 (Pubitemid 44871151)
26. S. Prabhu, M. Jainu, K.E. Sabitha, and C.S. Devi Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats Journal of Ethnopharmacology 107 2006 126 133 (Pubitemid 44038820)
27. P. Palsamy, and S. Subramanian Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling Biochimica et Biophysica Acta 1812 2011 719 731
28. M.A. Queisser, D. Yao, S. Geisler, H.P. Hammes, G. Lochnit, E.D. Schleicher, M. Brownlee, and K.T. Preissner Hyperglycemia impairs proteasome function by methylglyoxal Diabetes 59 2010 670 678
29. P. Rossing Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history Current Diabetes Reports 6 2006 479 483 (Pubitemid 44896409)
30. N. Reiniger, K. Lau, D. McCalla, B. Eby, B. Cheng, Y. Lu, W. Qu, N. Quadri, R. Ananthakrishnan, M. Furmansky, R. Rosario, F. Song, V. Rai, A. Weinberg, R. Friedman, R. Ramasamy, V. D'Agati, and A.M. Schmidt Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse Diabetes 59 2010 2043 2054
31. N. Rabbani, and P.J. Thornalley Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress Biochemical Society Transactions 36 2008 1045 1050
32. D. Suzuki, and T. Miyata Carbonyl stress in the pathogenesis of diabetic nephropathy Internal medicine (Tokyo) 38 1999 309 314
33. C.M. Sena, P. Matafome, J. Crisostomo, L. Rodrigues, R. Fernandes, P. Pereira, and R.M. Seiça Methylglyoxal promotes oxidative stress and endothelial dysfunction Pharmacological Research 65 2012 497 506
34. K. Sharma, P. McCue, and S.R. Dunn Diabetic kidney disease in the db/db mouse American Journal of Physiology - Renal Physiology 284 2003 F1138 F1144
35. M. Shinohara, P.J. Thornalley, I. Giardino, P. Beisswenger, S.R. Thorpe, J. Onorato, and M. Brownlee Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis Journal of Clinical Investigation 101 1998 1142 1147 (Pubitemid 28125293)
36. D. Suzuki, M. Toyoda, N. Yamamoto, M. Miyauchi, M. Katoh, M. Kimura, M. Maruyama, M. Honma, T. Umezono, and M. Yaganme Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy Internal Medicine 45 2006 435 441 (Pubitemid 43676579)
37. A.M. Schmidt, S.D. Yan, J.L. Wautier, and D. Stern Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis Circulation Research 84 1999 489 497 (Pubitemid 29138585)
38. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses Journal of Clinical Investigation 108 2001 949 955 (Pubitemid 32946067)
39. P.J. Thornalley Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation Biochemical Society Transactions 31 part 6 2003
40. P.J. Thornalley Dicarbonyl intermediates in the maillard reaction Annals of the New York Academy of Sciences 1043 2005 111 117 (Pubitemid 41123896)
41. N. Tanji, G.S. Markowitz, C. Fu, T. Kislinger, A. Taguchi, M. Pischetsrieder, D. Stern, A.M. Schmidt, and A.D. D'Agati Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease Journal of theAmerican Society of Nephrology 11 2000 1656 1666
42. S.Y. Tang, M. Whiteman, Z.F. Peng, A. Jenner, E.L. Yong, and B. Halliwell Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines Free Radical Biology and Medicine 36 2004 1575 1587 (Pubitemid 38746565)
43. J.L. Wautier, M.P. Wautier, A.M. Schmidt, G.M. Anderson, O. Hori, C. Zoukourian, L. Capron, O. Chappey, S.D. Yan, and J. Brett Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications Proceedings of the National Academy of Sciences of the United States of America 91 1994 7742 7746
44. D. Yao, and M. Brownlee Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands Diabetes 59 2010 249 255
45. Y. Yamamoto, I. Kato, T. Doi, H. Yonekura, S. Ohashi, M. Takeuchi, T. Watanabe, S. Yamagishi, S. Sakurai, S. Takasawa, H. Okamoto, and H. Yamamoto Development and prevention of advanced diabetic nephropathy in RAGE overexpressing mice Journal of Clinical Investigation 108 2001 261 268 (Pubitemid 32656250)
46. H. Yamawaki, K. Saito, M. Okada, and Y. Hara Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells American Journal of Physiology - Cell Physiology 295 2008 C1510 C1517
47. M. Yoshikawa, N. Nishida, H. Shimoda, M. Takada, Y. Kawahara, and H. Matsuda Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alphaglucosidase and aldose reductase inhibitory activities Yakugaku Zasshi 121 2001 371 378 (Pubitemid 32440588)
48. P.H. Yu Oxidative deamination of aliptatic amines by rat aorta semicarbazide-sensitive amine oxidase Journal of Pharmacy and Pharmacology 42 1990 882 884
49. P.H. Yu, and D.M. Zuo Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications Diabetologia 40 1997 1243 1250 (Pubitemid 27469662)